Insect cells as a new substrate for vaccine production

W Dalemans1

  • 1Regulatory Strategy and Development, GlaxoSmithKline Biologicals, Rixensart, Belgium. wilfried.dalemans@gskbio.com

Summary

Insect cell lines offer a novel platform for vaccine production. The Hi-5 insect cell line demonstrated satisfactory quality and safety for expressing human papilloma virus L1 antigen, suggesting a viable alternative for future vaccine manufacturing.